Citation Impact

Citing Papers

Hypogonadotropic hypogonadism due to loss of function of the KiSS1-derived peptide receptor GPR54
2003 Standout
The liver in hereditary haemorrhagic teleangiectasia: an inborn error of vascular structure with multiple manifestations: a reappraisal.
1978
Associations between insulin resistance and TNF-α in plasma, skeletal muscle and adipose tissue in humans with and without type 2 diabetes
2007
From stress to inflammation and major depressive disorder: A social signal transduction theory of depression.
2014 Standout
Health benefits of physical activity: the evidence
2006 Standout
Epidemiology and Natural History of Gastroparesis
2014
Body composition and energy expenditure: Relationship and changes in obese subjects before and after biliopancreatic diversion
2003
Bowel Disorders
2016 Standout
Circulating levels of TNF-alpha and IL-6-relation to truncal fat mass and muscle mass in healthy elderly individuals and in patients with type-2 diabetes
2003
Circulating Endothelial Progenitor Cells and Cardiovascular Outcomes
2005 Standout
Recommendations for the use of cardiovascular tests in diagnosing diabetic autonomic neuropathy☆
2011
The metabolic syndrome
2010 Standout
Obesity, adipocytokines, and insulin resistance in breast cancer
2004
Metabolic syndrome—a new world‐wide definition. A Consensus Statement from the International Diabetes Federation
2006 Standout
Effects of liraglutide (NN2211), a long‐acting GLP‐1 analogue, on glycaemic control and bodyweight in subjects with Type 2 diabetes
2005
The Human Intestinal Microbiome in Health and Disease
2016 Standout
Hereditary Hemorrhagic Telangiectasia
1995 Standout
The GPR54 Gene as a Regulator of Puberty
2003 Standout
Influence of Metabolic Syndrome on Biomarkers of Oxidative Stress and Inflammation in Obese Adults
2006
Postnatal developmental consequences of altered insulin sensitivity in female sheep treated prenatally with testosterone
2005
Abdominal Fat Assessment in Adolescents Using Dual-energy X-ray Absorptiometry
2009
Diagnosis and Treatment of Polycystic Ovary Syndrome: An Endocrine Society Clinical Practice Guideline
2013 Standout
Epidemiology and Outcome of Zygomycosis: A Review of 929 Reported Cases
2005 Standout
Cardiovascular autonomic neuropathy in diabetes: clinical impact, assessment, diagnosis, and management
2011
The metabolic syndrome
2005 Standout
Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms
2004 Standout
The Epidemiology of Pancreatitis and Pancreatic Cancer
2013 Standout
Lower functional gastrointestinal disorders: evidence of abnormal colonic transit in a 287 patient cohort
2009
The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes
2006 Standout
Diabetes and Atherosclerosis
2002 Standout
Monogenic Disorders of Puberty
2002
Mechanisms linking obesity to insulin resistance and type 2 diabetes
2006 StandoutNature
Obesity, lipids, cardiovascular risk, and androgen excess
1995
Heritable components of the human fecal microbiome are associated with visceral fat
2016
Type 1 diabetes
2013 Standout
Fibulin-5/DANCE is essential for elastogenesis in vivo
2002 StandoutNatureNobel
The effects of acute psychological stress on circulating inflammatory factors in humans: A review and meta-analysis
2007
Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies
2008 Standout
Risk factors for cardiac autonomic neuropathy in type 1 diabetes mellitus
2004
The evolution of β‐cell dysfunction and insulin resistance in type 2 diabetes
2002
Voxel-Based Morphometry—The Methods
2000 Standout
Angiotensin-Converting Enzyme Inhibition Partially Prevents Diabetic Organomegaly
1994
Behavioural treatments for chronic systemic inflammation: effects of dietary weight loss and exercise training
2005
Obesity and the polycystic ovary syndrome
2002
Aging of the extracellular matrix and its pathology
1988
Inappropriate Gonadotropin Secretion in Polycystic Ovary Syndrome: Influence of Adiposity1
1997
Prognostic value of cardiac autonomic neuropathy independent and incremental to perfusion defects in patients with diabetes and suspected coronary artery disease
2003
Reversal of Lesions of Diabetic Nephropathy after Pancreas Transplantation
1998 Standout
Early Endocrine, Metabolic, and Sonographic Characteristics of Polycystic Ovary Syndrome (PCOS): Comparison between Nonobese and Obese Adolescents
2003
Muscle as an Endocrine Organ: Focus on Muscle-Derived Interleukin-6
2008 Standout
Pathophysiology of Human Visceral Obesity: An Update
2013 Standout
Diagnosis and Management of the Metabolic Syndrome
2005 Standout
Criteria for Defining Polycystic Ovary Syndrome as a Predominantly Hyperandrogenic Syndrome: An Androgen Excess Society Guideline
2006 Standout
Use of Heart Rate Reserve and Rating of Perceived Exertion to Prescribe Exercise Intensity in Diabetic Autonomic Neuropathy
2003
From the Triumvirate to the Ominous Octet: A New Paradigm for the Treatment of Type 2 Diabetes Mellitus
2009 Standout
Adiposity and Insulin Resistance in Humans: The Role of the Different Tissue and Cellular Lipid Depots
2013
Exercise and Physical Activity for Older Adults
2009 Standout
Diabetic Neuropathies
2005 Standout
Supramolecular Hydrogelators and Hydrogels: From Soft Matter to Molecular Biomaterials
2015 Standout
Decreased Protection by HDL From Poorly Controlled Type 2 Diabetic Subjects Against LDL Oxidation May Be Due to the Abnormal Composition of HDL
1999
Pharmacological Approaches for the Treatment of Obesity
2002
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2019 Standout
Diabetic Cardiovascular Autonomic Neuropathy
2007
Gonadotropin-Releasing Hormone Deficiency in the Human (Idiopathic Hypogonadotropic Hypogonadism and Kallmann’s Syndrome): Pathophysiological and Genetic Considerations
1998
Obesity, endogenous hormones, and endometrial cancer risk: a synthetic review.
2002
ACC/AHA guidelines for coronary angiography11“ACC/AHA Guidelines for Coronary Angiography” was approved by the American College of Cardiology Board of Trustees in October 1998 and by the American Heart Association Science Advisory and Coordinating Committee in December 1998.22When citing this document, the American College of Cardiology and the American Heart Association request that the following format be used: Scanlon PJ, Faxon DP, Audet AM, Carabello B, Dehmer GJ, Eagle KA, Legako RD, Leon DF, Murray JA, Nissen SD, Pepine CJ, Watson RM. ACC/AHA guidelines for coronary angiography: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Coronary Angiography). J Am Coll Cardiol1999;33:1756–82433This document is available on the websites of the ACC (www.acc.org) and the AHA (www.americanheart.org). Reprints of this document (the complete guidelines) are available for $5 each by calling 800-253-4636 (US only) or writing the American College of Cardiology, Educational Services, 9111 Old Georgetown Road, Bethesda, MD 20814-1699. Ask for reprint No. 71-0164. To obtain a reprint of the shorter version (executive summary and summary of recommendations) published in the May 4, 1999, issue of Circulation, ask for reprint No. 71-0163. To purchase additional reprints (specify version and reprint number): up to 999 copies, call 800-611-6083 (US only) or fax 413-665-2671; 1000 or more copies, call 214-706-1466, fax 214-691-6342, or e-mail pubauth@heart.org
1999
Sex and Gender Differences in Risk, Pathophysiology and Complications of Type 2 Diabetes Mellitus
2016 Standout
The insulin resistance in women with hyperandrogenism is partially reversed by antiandrogen treatment: evidence that androgens impair insulin action in women.
1996
Effects of Prior Intensive Insulin Therapy on Cardiac Autonomic Nervous System Function in Type 1 Diabetes Mellitus
2009
Determinants of Abnormal Gonadotropin Secretion in Clinically Defined Women with Polycystic Ovary Syndrome1
1997
Insulin Resistance and the Polycystic Ovary Syndrome: Mechanism and Implications for Pathogenesis*
1997 Standout
Cutaneous mucormycosis: A rare cause of leg ulceration
1986
Diabetic Neuropathies: Update on Definitions, Diagnostic Criteria, Estimation of Severity, and Treatments
2010 Standout
Physical Activity and Public Health in Older Adults
2007 Standout
Physical Activity/Exercise and Type 2 Diabetes
2004
The Concurrent Accumulation of Intra-Abdominal and Subcutaneous Fat Explains the Association Between Insulin Resistance and Plasma Leptin Concentrations
2002
Adipocytokines Attenuate the Association Between Visceral Adiposity and Diabetes in Older Adults
2004
Overexpression of fibronectin induced by diabetes or high glucose: phenomenon with a memory.
1990
The Metabolic Syndrome
2008 Standout
Physical Activity/Exercise and Diabetes: A Position Statement of the American Diabetes Association
2016 Standout
Meta-Analysis: Surgical Treatment of Obesity
2005 Standout
Insulin Resistance and the Polycystic Ovary Syndrome Revisited: An Update on Mechanisms and Implications
2012 Standout
Diabetic Neuropathy: A Position Statement by the American Diabetes Association
2016 Standout
Abdominal Visceral and Subcutaneous Adipose Tissue Compartments
2007 Standout
Diabetic Autonomic Neuropathy
2003 Standout
Intra-Abdominal Fat Is a Major Determinant of the National Cholesterol Education Program Adult Treatment Panel III Criteria for the Metabolic Syndrome
2004
Obesity and Fat Distribution Imply a Greater Systemic Inflammatory Response and a Worse Prognosis in Acute Pancreatitis
2008
Peripheral neuropathy and the risk of cardiovascular events in type 2 diabetes mellitus
2014
The Metabolic Syndrome: Time for a Critical Appraisal
2005 Standout
Detection of Silent Myocardial Ischemia in Asymptomatic Diabetic Subjects
2004
The anti-inflammatory effect of exercise
2005 Standout
Chitosan Chemistry and Pharmaceutical Perspectives
2004 Standout
Antiinflammatory Properties of HDL
2004 Standout
Angiotensin Blockade Improves Cardiac and Renal Complications of Type II Diabetic Rats
1997 StandoutNobel
Kallmann’s syndrome
1999
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2019 Standout
Insulin, somatotropic, and luteinizing hormone axes in lean and obese women with polycystic ovary syndrome: common and distinct features.
1996

Works of M Leuténegger being referenced

Measurement of visceral adipose tissue by DXA combined with anthropometry in obese humans
2000
Postprandial cholesteryl ester transfer and high density lipoprotein composition in normotriglyceridemic non-insulin-dependent diabetic patients
1996
Roles of LH and insulin resistance in lean and obese polycystic ovary syndrome
1993
Study of the rate of early glucose disappearance following insulin injection: insulin sensitivity index
1993
Heterogeneity in the mutations responsible for X chromosome-linked Kallmann syndrome
1993
Added benfluorex in obese insulin-requiring type 2 diabetes.
1998
Plasma and tissue fibronectin in diabetes.
1984
Silent myocardial ischaemia and left ventricle hypertrophy in diabetic patients.
1997
Mucormycose cutanée chez une diabétique Problèmes diagnostiques et thérapeutiques
1984
[Rendu-Osler disease with multivisceral localizations].
1972
Distribution of fibronectin in diabetic skin.
1983
Plasma levels of tumor necrosis factor-alpha (TNF-alpha) are essentially dependent on visceral fat amount in type 2 diabetic patients.
2000
Gastric emptying is accelerated in obese type 2 diabetic patients without autonomic neuropathy.
2001
Predictive Value of Cardiac Autonomic Neuropathy in Diabetic Patients With or Without Silent Myocardial Ischemia
2001
Rankless by CCL
2026